Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project.

about

Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project.

Item

http://www.wikidata.org/entity/Q38693665

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Persistent impairments 3 years ...... esults from the MaTox project.

@en

type

Item

label

Persistent impairments 3 years ...... esults from the MaTox project.

@en

prefLabel

Persistent impairments 3 years ...... esults from the MaTox project.

@en

P1476

Persistent impairments 3 years ...... results from the MaTox project

@en

P2093

Hans Tesch

http://www.w3.org/2001/XMLSchema#string

Hans-Jürgen Hurtz

http://www.w3.org/2001/XMLSchema#string

Johanna Harde

http://www.w3.org/2001/XMLSchema#string

Lisa Kruggel

http://www.w3.org/2001/XMLSchema#string

Martina Jänicke

http://www.w3.org/2001/XMLSchema#string

TMK-Group (Tumour Registry Breast Cancer)

http://www.w3.org/2001/XMLSchema#string

Thomas Göhler

http://www.w3.org/2001/XMLSchema#string

Ulrich Hutzschenreuter

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy-induced peripheral neurotoxicity: a critical analysis

Cancer treatment and survivorship statistics, 2012

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Quality of life assessment in women with breast cancer: benefits, acceptability and utilization

Changing profile of joint disorders with age: findings from a postal survey of the population of Calderdale, West Yorkshire, United Kingdom

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer.

Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.

Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancer

P2888

s10549-017-4365-7

P304

721-731

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-017-4365-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P50

Norbert Marschner

P577

2017-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090358733

http://www.w3.org/2001/XMLSchema#string

P698

28677012

http://www.w3.org/2001/XMLSchema#string

P932

5602000

http://www.w3.org/2001/XMLSchema#string